arrow
P

Po-Cheng Liang

kaohsiung medical university
H指数:18
被引数:1,302

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE‐B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B

在慢性乙型肝炎患者中,将层粘连蛋白γ2单体加入PAGE-B评分以用于肝细胞癌监测的临床应用价值

2026-10-080
PRE
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪性肝病中用于疾病严重程度预测的心血管代谢生物标志物

2026-09-130
OAAI
Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD

ADH1B rs1229984基因多态性与CT衰减值评估的肝脂肪变性之间的关联:中央性肥胖在MASLD中的中介分析

2026-09-070
PRE
Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B

慢性乙型肝炎患者中环境氮氧化物暴露与肝脂肪变性的关联

2026-05-190
OAAI
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy

慢性丙型肝炎患者经治愈性抗病毒治疗后,心血管代谢危险因素和脂肪性肝病对肝脏相关结局的影响

2026-04-220
OAAI
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study

将动脉内疗法加入免疫疗法可改善不可切除性肝细胞癌的预后:台湾多中心队列研究

2026-01-010
PRE
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD

FIB-4作为MASLD患者冠状动脉钙化的转诊指数

2025-11-010
PRE
Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan

台湾终末期肾病血液透析患者中全国性丙型肝炎病毒微消除

2025-09-130
PREAI
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B

脂肪性肝病相关多基因风险评分对核苷/核苷酸类似物治疗的慢性乙型肝炎患者肝细胞癌的预测

2025-07-240
PRE
Circulating let-7 Predicts Hepatic Fibrogenesis of 12-Month Post-Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus

循环let-7可预测核苷(类)类似物治疗12个月后乙型肝炎病毒患者的肝纤维化进展

2025-03-290
OAAI
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

线粒体mt12361A>G增加非糖尿病患者代谢功能障碍相关的脂肪性肝病的风险

2025-03-140
PRE
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
2024-11-261
PRE
Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality

接受预防性核苷 (酸) 类似物化疗的癌症患者乙型肝炎病毒复发的评估: 对总体死亡率的影响

2024-07-100
PRE